JHP Pharmaceuticals announced that the FDA has approved its rapidly-mixing formulation of Dantrium IV (dantrolene sodium for injection), designed to save time and effort during the emergency treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results